Noble Hospital Comprehensive Breast Program in Massachusetts Pioneers Breast Cancer Risk Assessment
January 14, 2013 10:15 ET | Noble Hospital
SPRINGFIELD, Mass., Jan. 14, 2013 (GLOBE NEWSWIRE) -- Dr. Steven Schonholz, Director of the Comprehensive Breast Program at Noble Hospital, is one of the first physicians in the nation to make the...
Atossa Genetics to Present at OneMedForum and Biotech Showcase
January 03, 2013 08:30 ET | Atossa Genetics, Inc.
SEATTLE, WA--(Marketwire - Jan 3, 2013) - Atossa Genetics, Inc. (NASDAQ: ATOS) announced today that Dr. Steven C. Quay, M.D., Ph.D., FCAP, Chairman, CEO and President, will present at the...
Primary Care Associates of Bellevue Pioneers Breast Cancer Risk Assessment
September 24, 2012 12:16 ET | Primary Care Associates P.S.
BELLEVUE, WASH., Sept. 24, 2012 (GLOBE NEWSWIRE) -- Dr. Lisa Steffensen of Primary Care Associates is one of the first physicians in the nation to make the BREVAGen™ predictive risk test...
Photo Release -- Rolling Oaks Radiology and GE Healthcare Partner to Explore Applications for a New Mammogram Technology
July 24, 2012 16:09 ET | RadNet, Inc.
OXNARD, Calif., July 24, 2012 (GLOBE NEWSWIRE) -- Rolling Oaks Radiology, a division of RadNet, Inc. (Nasdaq:RDNT), a national market leader providing high-quality, cost-effective diagnostic imaging...
Atossa Genetics, Inc. Appoints Robert L. Kelly as President
May 25, 2010 09:00 ET | Atossa Genetics, Inc.
SEATTLE, WA--(Marketwire - May 25, 2010) -  Atossa Genetics, Inc., a privately-held healthcare company focused on the development and marketing of leading edge and unique cellular and molecular...
Atossa Genetics, Inc. Appoints Edward Sauter, M.D., Ph.D., to Its Scientific Advisory Board
February 25, 2010 11:00 ET | Atossa Genetics, Inc.
SEATTLE, WA--(Marketwire - February 25, 2010) -  Atossa Genetics, Inc., a privately-held healthcare company focused on the development and marketing of novel cellular and molecular diagnostic...
Atossa Genetics, Inc. Launches Corporate Web Site Featuring New FDA-Approved Breast Cancer Risk Assessment Test
February 08, 2010 08:30 ET | Atossa Genetics, Inc.
SEATTLE, WA--(Marketwire - February 8, 2010) - Atossa Genetics, Inc., a privately-held healthcare company focused on the development and marketing of novel cellular and molecular diagnostic...